Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Lokivetmab reduced itching in a dog with skin lymphoma.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

A cat had a rare severe reaction to fenbendazole, but recovered with treatment.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.